Titulo:
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama
.
Guardado en:
0121-7372
2462-991X
31
2022-11-15
223
229
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Revista Repertorio de Medicina y Cirugía - 2022
| id |
metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98-article-1119 |
|---|---|
| record_format |
ojs |
| spelling |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama 31 Bautista Saiz, Carolina Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Artículo de revista Núm. 3 , Año 2022 : Septiembre - Diciembre 3 Revista Repertorio de Medicina y Cirugía Mora Gómez , Monica María Polo, José Fernando Gutiérrez Castañeda, Luz Dary Journal article http://purl.org/coar/version/c_970fb48d4fbd8a85 Alcalde J, González-Muñoz M, Villalobo A. Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate. Heliyon. 2020;6(5):e03922. https://doi.org/10.1016/j.heliyon.2020.e03922 Bai T, Luoh SW. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis. 2008;29(3):473-9. doi: 10.1093/carcin/bgm221 Bradford AM, Koirala R, Park CK, Lyons BA. Characterization of the full-length human Grb7 protein and a phosphorylation representative mutant. J Mol Recognit. 2019;32(11):e2803. doi: 10.1002/jmr.2803 Villalobo A, Ishida H, Vogel HJ, Berchtold MW. Calmodulin as a protein linker and a regulator of adaptor/scaffold proteins. Biochim Biophys Acta Mol Cell Res. 2018;1865(3):507-21. doi: 10.1016/j.bbamcr.2017.12.004 García-Palmero I, Shah N, Ali NA, Daly RJ, Wilce JA, Villalobo A. Partners of wild type Grb7 and a mutant lacking its calmodulin-binding domain. Arch Biochem Biophys. 2020;687:108386. doi: 10.1016/j.abb.2020.108386 Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE. Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem. 1997;272(5):2659-67. doi: 10.1074/jbc.272.5.2659 Watson GM, Kulkarni K, Brandt R, Del Borgo MP, Aguilar MI, Wilce JA. Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide. ACS Omega. 2017;2(2):670-677. doi: 10.1021/acsomega.6b00561 Han DC, Shen TL, Guan JL. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene. 2001;20(44):6315-21. doi: 10.1038/sj.onc.120477 Katoh K. FAK-Dependent Cell Motility and Cell Elongation. Cells. 2020;9(1):192. doi: 10.3390/cells9010192 Watson GM, Wilce JA. Direct Interaction between Calmodulin and the Grb7 RA-PH Domain. Int J Mol Sci. 2020;21(4):1336. doi: 10.3390/ijms21041336. Shen TL, Guan JL. Grb7 in intracellular signaling and its role in cell regulation. Front Biosci. 2004;9:192-200. doi: 10.2741/1229 Watson GM, Lucas WAH, Gunzburg MJ, Wilce JA. Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target. Front Mol Biosci. 2017;4:64. doi: 10.3389/fmolb.2017.00064 Gotovac JR, Liu DS, Yates MJ, Milne JV, Macpherson AA, Simpson KJ, et al. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma. J Pathol. 2020;252(3):317-329. doi: 10.1002/path.5528 Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, et al. A novel variant of human Grb7 is associated with invasive esophageal carcinoma. J Clin Invest. 1998;102(4):821-7. doi: 10.1172/JCI2921 Sang J, Kulkarni K, Watson GM, Ma X, Craik DJ, Henriques ST, et al. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity. Molecules. 2019;24(20):3739. doi: 10.3390/molecules24203739. Tang Y, Yang S, Wang M, Liu D, Liu Y, Zhang Y, et al. Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7. Int J Mol Med. 2019;43(6):2352-60. doi: 10.3892/ijmm.2019.4167 Lucas-Fernández E, García-Palmero I, Villalobo A. Genomic organization and control of the grb7 gene family. Curr Genomics. 2008;9(1):60-68. doi: 10.2174/138920208783884847 Pradip D, Bouzyk M, Dey N, Leyland-Jones B. Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. Am J Cancer Res. 2013;3(2):173-95. Tai YL, Tung LH, Lin YC, Lu PJ, Chu PY, Wang MY, et al. Grb7 Protein Stability Modulated by Pin1 in Association with Cell Cycle Progression. PLoS One. 2016;11(9):e0163617. doi: 10.1371/journal.pone.0163617 Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, et al. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000;14(11):1750-75. doi: 10.1210/mend.14.11.0553 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2240 http://purl.org/redcol/resource_type/ARTREV http://purl.org/coar/resource_type/c_dcae04bc http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text info:eu-repo/semantics/article https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2241 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2224 Watson GM, Kulkarni K, Sang J, Ma X, Gunzburg MJ, Perlmutter P, et al. Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target. J Med Chem. 2017;60(22):9349-59. https://doi.org/10.1021/acs.jmedchem.7b01320 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/1863 Watson GM, Gunzburg MJ, Ambaye ND, Lucas WAH, Traore DA, Kulkarni K, et al. Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target. J Med Chem. 2015;58(19):7707-18. doi: 10.1021/acs.jmedchem.5b00609 Luoh SW, Ramsey B, Hanlon Newell A, Troxell M, Hu Z, Chin K, et al. HER-2 gene amplification in human breast cancer without concurrent HER-2 over-expression. Springerplus. 2013;2:386. doi: 10.1186/2193-1801-2-386 Bivin WW, Yergiyev O, Bunker ML, Silverman JF, Krishnamurti U. GRB7 Expression and Correlation With HER2 Amplification in Invasive Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2017;25(8):553-558. doi: 10.1097/PAI.0000000000000349 Vermehren-Schmaedick A, Mhawech-Fauceglia P, Park BS, Pejovic T, Luoh SW. The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers. Oncotarget. 2020;11(24):2273-2289. doi: 10.18632/oncotarget.27593 Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, et al. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 1994;13(6):1331-40. Giricz O, Calvo V, Pero SC, Krag DN, Sparano JA, Kenny PA. GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Res Treat. 2012;133(2):607-15. doi: 10.1007/s10549-011-1822-6 info:eu-repo/semantics/publishedVersion Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, et al. Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Clinical Cancer Research. 2011;17(22):7194-203. doi: 10.1158/1078-0432.CCR-10-3357 Luoh SW, Wagoner W, Wang X, Hu Z, Lai X, Chin K, et al. GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling. Mol Carcinog. 2019;58(5):699-707. doi: 10.1002/mc.22963 Chu PY, Tai YL, Shen TL. Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. Cells. 2019;8(5):435. doi: 10.3390/cells8050435 2022-11-15 09:42:55 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1119 2462-991X 0121-7372 audio/mpeg application/epub+zip text/html application/pdf 2022-11-15 2022-11-15 09:42:55 https://doi.org/10.31260/RepertMedCir.01217372.1119 signal transduction breast cancer growth factor receptor-bound protein 7 GRB7 ERBB-2 genes transducción de señal cáncer de mama proteína 7 unida al receptor del factor de crecimiento GRB7 genes ERBB-2 10.31260/RepertMedCir.01217372.1119 Kushwaha PP, Gupta S, Singh AK, Kumar S. Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis. Front Oncol. 2019;9:868. doi: 10.3389/fonc.2019.00868 Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52. doi: 10.1038/35021093. Van Treuren T, Vishwanatha JK. CRISPR deletion of MIEN1 in breast cancer cells. PLoS One. 2018;13(10):e0204976. doi: 10.1371/journal.pone.0204976 Zhao HB, Zhang XF, Wang HB, Zhang MZ. Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target. Genet Mol Res. 2017;16(1). doi: 10.4238/gmr16019380 Yin K, Ba Z, Li C, Xu C, Zhao G, Zhu S, et al. Overexpression of C35 in breast carcinomas is associated with tumor progression and lymphnode metastasis. Biosci Trends. 2015;9(6):386-92. doi: 10.5582/bst.2015.01161 Kpetemey M, Chaudhary P, Van Treuren T, Vishwanatha JK. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics. Oncotarget. 2016;7(34):54913-24. Nadler Y, González AM, Camp RL, Rimm DL, Kluger HM, Kluger Y. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Ann Oncol. 2010;21(3):466-73. doi: 10.1093/annonc/mdp346 Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, et al. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Clin Cancer Res. 2005;11(23):8348-57. doi: 10.1158/1078-0432.CCR-05-0841 Kalinowski L, Saunus JM, McCart Reed AE, Lakhani SR. Breast Cancer Heterogeneity in Primary and Metastatic Disease. Adv Exp Med Biol. 2019;1152:75-104. doi: 10.1007/978-3-030-20301-6_6 Serrano Gómez S. Perfil molecular del cáncer de mama en la población colombiana: Pontificia Universidad Javeriana; 2016. Godone RLN, Leitão GM, Araújo NB, Castelletti CHM, Lima-Filho JL, Martins DBG. Clinical and molecular aspects of breast cancer: Targets and therapies. Biomed Pharmacother. Biomed Pharmacother. 2018;106:14-34. doi: 10.1016/j.biopha.2018.06.066 https://creativecommons.org/licenses/by-nc-sa/4.0 Behravan H, Hartikainen JM, Tengström M, Kosma VM, Mannermaa A. Predicting breast cancer risk using interacting genetic and demographic factors and machine learning. Sci Rep. 2020;10(1):11044. doi: 10.1038/s41598-020-66907-9 World Health Organization. Colombia Source: Globocan 2018 The global cancer observatory [Internet]. 2018 [Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf. Diaz Casas S, Lancheros García E, Sanchéz Campo A, Sanchez Pedraza R, Roman Vasquez V, Mendoza SD, et al. Clinical Behavior of Triple Negative Breast Cancer in a Cohort of Latin American Women. Cureus. 2019;11(6):e4963. doi: 10.7759/cureus.4963 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492 229 223 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Revista Repertorio de Medicina y Cirugía - 2022 Publication |
| institution |
FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD |
| thumbnail |
https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png |
| country_str |
Colombia |
| collection |
Revista Repertorio de Medicina y Cirugía |
| title |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama |
| spellingShingle |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama Bautista Saiz, Carolina Mora Gómez , Monica María Polo, José Fernando Gutiérrez Castañeda, Luz Dary signal transduction breast cancer growth factor receptor-bound protein 7 GRB7 ERBB-2 genes transducción de señal cáncer de mama proteína 7 unida al receptor del factor de crecimiento GRB7 genes ERBB-2 |
| title_short |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama |
| title_full |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama |
| title_fullStr |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama |
| title_full_unstemmed |
La proteína 7 unida al receptor del factor de crecimiento (GRB7) en cáncer de mama |
| title_sort |
la proteína 7 unida al receptor del factor de crecimiento (grb7) en cáncer de mama |
| author |
Bautista Saiz, Carolina Mora Gómez , Monica María Polo, José Fernando Gutiérrez Castañeda, Luz Dary |
| author_facet |
Bautista Saiz, Carolina Mora Gómez , Monica María Polo, José Fernando Gutiérrez Castañeda, Luz Dary |
| topic |
signal transduction breast cancer growth factor receptor-bound protein 7 GRB7 ERBB-2 genes transducción de señal cáncer de mama proteína 7 unida al receptor del factor de crecimiento GRB7 genes ERBB-2 |
| topic_facet |
signal transduction breast cancer growth factor receptor-bound protein 7 GRB7 ERBB-2 genes transducción de señal cáncer de mama proteína 7 unida al receptor del factor de crecimiento GRB7 genes ERBB-2 |
| citationvolume |
31 |
| citationissue |
3 |
| citationedition |
Núm. 3 , Año 2022 : Septiembre - Diciembre |
| publisher |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| ispartofjournal |
Revista Repertorio de Medicina y Cirugía |
| source |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1119 |
| language |
|
| format |
Article |
| rights |
info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-sa/4.0 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Revista Repertorio de Medicina y Cirugía - 2022 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_dcae04bc |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2022-11-15 |
| date_accessioned |
2022-11-15 09:42:55 |
| date_available |
2022-11-15 09:42:55 |
| url |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1119 |
| url_doi |
https://doi.org/10.31260/RepertMedCir.01217372.1119 |
| issn |
0121-7372 |
| eissn |
2462-991X |
| doi |
10.31260/RepertMedCir.01217372.1119 |
| citationstartpage |
223 |
| citationendpage |
229 |
| url5_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2240 |
| url7_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2241 |
| url3_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/2224 |
| url2_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1119/1863 |
| _version_ |
1828994803453394944 |